McManus, E. ORCID: https://orcid.org/0000-0002-3442-8721, Sach, T.
ORCID: https://orcid.org/0000-0002-8098-9220 and Levell, N. J.
ORCID: https://orcid.org/0000-0003-3393-8305
(2018)
Are vitiligo treatments cost-effective? A systematic review.
British Journal of Dermatology, 178 (1).
e57–e58.
ISSN 0007-0963
Preview |
PDF (Accepted manuscript)
- Accepted Version
Download (413kB) | Preview |
Abstract
Vitiligo is characterised by well demarcated, cutaneous, macular depigmentation, with worldwide prevalence estimated to be between 0.2-1.8% [1]. Vitiligo treatments aim to encourage re-pigmentation and include topical corticosteroids, calcineurin inhibitors and NB-UVB phototherapy. Camouflage can also be prescribed to help mask the appearance of vitiligo, although this is frequently only prescribed for the face.
Item Type: | Article |
---|---|
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Related URLs: | |
Depositing User: | Pure Connector |
Date Deposited: | 15 Aug 2017 05:06 |
Last Modified: | 22 Oct 2022 02:59 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/64481 |
DOI: | 10.1111/bjd.15881 |
Actions (login required)
![]() |
View Item |